 |
인쇄하기
취소
|
Price determination of new leukemia drug to be delayed
The Ministry for Health, Welfare and Family Affair committee's decision on the price of Sprycel, a new drug for the disease, will be delayed, following its April 28 meeting.
The National Health Insurance Corp. suggested 51,000 won, while Bristol-Myers Squibb (BMS), the maker of the drug, is trying to get 609,000 won per 70-milligram-pill. Now it is up to the ministry to moderate the figure.
...
The National Health Insurance Corp. suggested 51,000 won, while Bristol-Myers Squibb (BMS), the maker of the drug, is trying to get 609,000 won per 70-milligram-pill. Now it is up to the ministry to moderate the figure.
...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.